Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
Logo Image
|Articles|April 2, 2019

INTERPHEX 2019 Keynote Series Presents Session on 3D Printing in Pharma

3D printing offers a new design freedom for bio/pharmaceutical manufacturing: whether for “printing” a solid-dosage drug or for creating a piece of equipment for bio/pharmaceutical laboratories or manufacturing facilities.

Pharmaceutical Technology will present the INTERPHEX Keynote Series: 3D Printing Applications in Pharma on Tuesday, April 2, 2019 from 1:30 to 3:00 pm. The session will be held on the show floor at the Innovation Stage and is open to all show attendees.

3D Printing Applications in Pharma

Three-dimensional printing (3DP)-also called additive manufacturing-is increasing in use in a range of healthcare industries, for printing customized prosthetics, for example, and for making models doctors can use to plan a surgery. 3DP also offers a new design freedom for bio/pharmaceutical manufacturing-whether for “printing” a solid-dosage drug or for creating a piece of equipment for bio/pharmaceutical laboratories or manufacturing facilities. 3DP is being used commercially in the pharmaceutical industry today, and additional uses are being investigated for the processes and equipment of tomorrow. 

Moderator: Jennifer Markarian, manufacturing editor, Pharmaceutical Technology. 

1:30­–2:15 pm3D Printing of Pharmaceuticals and Accelerating Drug Development 

Aprecia Pharmaceutical’s Spritam tablets became the first 3D-printed drug approved by FDA in August 2015. This session will discuss how three-dimensional (3D) printing of pharmaceuticals provides an opportunity to speed the drug development process, particularly during clinical trials due to its agile manufacturing process, allowing for rapid prototyping and potentially on-demand production. 

Speaker: Timothy S. Tracy, PhD, CEO of Aprecia Pharmaceuticals
Learn more

2­:15–3 pmAccelerating Additive Manufacturing for Bio/Pharma

In 2017, GE Healthcare opened a 3D printing lab at its technology center in Uppsala, Sweden to investigate how 3DP can speed the launch of innovative products. A 3D-printed chromatography column, for example, was custom-designed for a biopharmaceutical purification process. This session will discuss uses of 3DP in bio/pharma.

Speaker: Christel Fenge, PhD, head of R&D for GE Healthcare, Uppsala, Sweden
Learn more

Click here to see more show information.

Click here and use promo code IPXREG to register for INTERPHEX.

Related to this article

View more
The Promise of Microgravity for R&D and Manufacturing
The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.
Read more
The BioPharm Brief: An AI-Designed Multibody ADC Enters the Clinic, Blackstone Backs Pfizer’s Monthly GLP-1, and enGene Readies a Bladder Cancer BLA
The BioPharm Brief: An AI-Designed Multibody ADC Enters the Clinic, Blackstone Backs Pfizer’s Monthly GLP-1, and enGene Readies a Bladder Cancer BLA
FDA clears the IND for Biolojic Design’s BD200, an AI-designed Trop2/Nectin-4 multibody ADC; Blackstone Life Sciences agrees to provide Pfizer up to $1.5 billion to develop its monthly GLP-1 receptor agonist berobenatide; and enGene Therapeutics plans a year-end BLA for detalimogene voraplasmid in BCG-unresponsive non-muscle invasive bladder cancer.
Read more